Actinogen Medical (ATGGF) Income Statement
Actinogen Medical Income Statement
Last quarter (Q4 2026), Actinogen Medical 's total revenue was $0.00, a decrease of 100.00% from the same quarter last year. In Q4, Actinogen Medical 's net income was $-4.03M. See Actinogen Medical ’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 5.49M | $ 9.93M | $ 4.89M | $ 3.64M | |
| $ -419.27K | $ 5.49M | $ 9.93M | $ 4.48M | $ 3.24M | |
| $ 27.69M | $ 20.42M | $ 22.77M | $ 15.47M | $ 12.77M | |
| Depreciation and Amortization | $ 419.27K | $ 422.20K | $ 416.83K | $ 405.61K | $ 400.67K |
| $ -27.69M | $ -14.93M | $ -12.84M | $ -15.22M | $ -12.72M | |
| $ -28.11M | $ -14.93M | $ -12.84M | $ -15.87M | $ -13.17M | |
| $ 59.82K | $ 199.78K | $ -10.14M | $ 232.88K | $ 35.99K | |
| $ -28.05M | $ -14.73M | $ -22.98M | $ -15.64M | $ -13.14M | |
| $ -15.38M | $ -14.73M | $ -13.04M | $ -10.75M | $ -9.50M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.00 | $ -0.00 | $ -0.01 | $ -0.01 | $ -0.01 |
| Diluted EPS | $ -0.00 | $ -0.00 | $ -0.01 | $ -0.01 | $ -0.01 |
| Weighted Average Shares Outstanding | 3.33B | 2.98B | 2.17B | 1.88B | 1.79B |
| Weighted Average Shares Outstanding (Diluted) | 3.33B | 2.98B | 2.17B | 1.88B | 1.79B |
Currency in AUD
